Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Comment by donkeyfeatherson Apr 06, 2023 10:31am
272 Views
Post# 35382942

RE:No Downside Risk

RE:No Downside Risk

What I find fascinating is the sense that the company’s response is a reaction to something recent in nature, rather than something that has been brewing for 5 years.  The fact that shareholders have been questioning the motivations of Ray Matthews and the capacity limits of Phillip is not the exclusive concern of what is now a group defined as dissident.  Whoever decided that the problem shareholders have is limited to a few high share count holders…is the problem.  Treating all shareholders as somehow incapable of understanding the big picture here is pretty insulting.  We may not be aware of every detail, but we do see how long this is taking because of the many missteps (won’t list them all here).  If ever the company had put a list together that admitted the mistakes and then shown how, and by when, each of those problems would be resolved…there would be no dissidents.  You keep Ray Matthews around instead of resolve the problem.  You say we’ll put Phillip in the right seat, and then don’t.  All the pandering in the world is not a proxy for being accountable for an agenda that does not align with shareholder wishes.  The shareholders did not start this.  The dissidents are simply the product of insult after insult.  I hope that Spain acts as a place of reflection over reaction.

DF

<< Previous
Bullboard Posts
Next >>